This interactive session allows participants to test their knowledge of child and adolescent psychopharmacology concepts. Panelists Boris Birmaher, MD, Adelaide S. Robb, MD, MS, and John T. Walkup, MD will lead attendees through a series of multiple-choice questions and lively discussions moderated by Eric Williams, MD. Results are tallied instantly, providing participants with immediate feedback and avenues for further study. This session meets continuing certification (CC) requirements for self-assessment and assists participants in identifying and articulating goals they can incorporate into a professional development plan.

Members: $125/Non-Members: $175

Here’s What’s Included:

  • Test your knowledge of child and adolescent psychopharmacology
  • Learn from experts in the field 
  • Earn 8 ABPN-approved SACME credits


Eric R. Williams, MD
University of South Carolina


Boris Birmaher, MD
University of Pittsburgh

Adelaide S. Robb, MD
Children's National Hospital

Jeffrey R. Strawn, MD
University of Cincinnati


Learning Objectives:

At the conclusion of this continuing medical education activity, the participant will be able to:

  1. Document strengths in specific practice areas of psychopharmacology.
  2. Identify opportunities for improvement of the psychopharmacologic treatment of children and adolescents.
  3. Develop goals and form a framework for a professional development plan.

CME Credit

The American Academy of Child and Adolescent Psychiatry is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Academy of Child and Adolescent Psychiatry designates this other activity (live internet virtual activity with further study) for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Board of Psychiatry and Neurology has reviewed Helping You Know What You Don’t Know: A Self-Assessment Review of Psychopharmacology and has approved this product as part of a comprehensive CME and self-assessment program, which is mandated by the ABMS as a necessary component of continuing certification.